Search Results

Findings from Harvard University Has Provided New Data on Chemicals and Chemistry (Prediction Error In Dopamine Neurons During Associative Learning).

• Source: Journal of Technology & Science. 2024, pages. 928

Record details

Rise and Fall.

• Authors : Bednar, Joseph

Subjects: *ICE (Drug); *HEALTH; *DOPAMINEMASSACHUSETTS

• Source: BusinessWest. 5/12/2008, Vol. 24 Issue 26, p47-48. 2p.

Record details

Dopamine May Exacerbate Parkinson's Disease.

• Authors : Couzin, Jennifer

Subjects: *PARKINSON'S disease; *DOPAMINE; *PHYSIOLOGYMASSACHUSETTS; BOSTON (Mass.); UNITED States

• Source: Science Now. 11/12/2001, p4. 2p. 1 Black and White Photograph.

Record details

Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.

• Authors : Mangili, Federica; Giardino, Elena; Treppiedi, Donatella

• Source: Neuroendocrinology. June 1, 2021, Vol. 111 Issue 6, p568, 12 p.

Record details

Researchers at Massachusetts General Hospital Have Reported New Data on Impulse Control Disorders (Impulse Control Disorders In Hyperprolactinemic Patients On Dopamine Agonist Therapy).

• Source: Mental Health Weekly Digest. 2022, pages. 440

Record details

Data on Attention Deficit Hyperactivity Disorders Described by Researchers at Boston University (Rodent Models of Attention-deficit Hyperactivity Disorder: an Updated Framework for Model Validation and Therapeutic Drug Discovery).

• Source: Mental Health Weekly Digest. 2022, pages. 170

Record details

Studies from Broad Institute of Harvard & MIT Yield New Information about Genetic Risk (Single-cell Genomic Profiling of Human Dopamine Neurons Identifies a Population That Selectively Degenerates In Parkinson's Disease).

• Source: Health & Medicine Week. 2022, pages. 6682

Record details

Studies from McLean Hospital in the Area of Biomarkers Described (The Dopamine Transporter Gene Slc6a3: Multidisease Risks).

• Source: Health & Medicine Week. 2021, pages. 6318

Record details

Safinamide an appealing adjunct in Parkinson's disease.

• Authors : Sullivan, Suzanne

Subjects: *DOPAMINE agonists; *PARKINSON'S disease treatment; *ACTIVITIES of daily livingBOSTON (Mass.); MASSACHUSETTSAMERICAN Academy of Neurology AMERICAN Academy of Neurology AMERICAN Academy of Neurology 088699699

• Source: CNS Disorders Today. 5/26/2007, Issue 101, p3-4. 2p.

Record details

Researchers from Harvard University Provide Details of New Studies and Findings in the Area of Schizophrenia (Synaptic Effects of Dopamine Breakdown and Their Relation to Schizophrenia-Linked Working Memory Deficits).

• Source: Mental Health Business Week. 2018, pages. 519

Record details